These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 17239445)

  • 1. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
    Neumann H; Takahashi K
    J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.
    Kiialainen A; Hovanes K; Paloneva J; Kopra O; Peltonen L
    Neurobiol Dis; 2005 Mar; 18(2):314-22. PubMed ID: 15686960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.
    Takahashi K; Rochford CD; Neumann H
    J Exp Med; 2005 Feb; 201(4):647-57. PubMed ID: 15728241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
    Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
    J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective.
    Xing J; Titus AR; Humphrey MB
    Res Rep Biochem; 2015; 5():89-100. PubMed ID: 26478868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 in CNS homeostasis and neurodegenerative disease.
    Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
    Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.
    Fenoglio C; Galimberti D; Piccio L; Scalabrini D; Panina P; Buonsanti C; Venturelli E; Lovati C; Forloni G; Mariani C; Bresolin N; Scarpini E
    Neurosci Lett; 2007 Jan; 411(2):133-7. PubMed ID: 17088018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in TREM2 lead to pure early-onset dementia without bone cysts.
    Chouery E; Delague V; Bergougnoux A; Koussa S; Serre JL; Mégarbané A
    Hum Mutat; 2008 Sep; 29(9):E194-204. PubMed ID: 18546367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
    Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurodegenerative disease and TREM2].
    Takahashi K
    Rinsho Shinkeigaku; 2014; 54(12):1122-4. PubMed ID: 25519966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TREM2 sustains microglial expansion during aging and response to demyelination.
    Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
    J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice.
    Frank S; Burbach GJ; Bonin M; Walter M; Streit W; Bechmann I; Deller T
    Glia; 2008 Oct; 56(13):1438-47. PubMed ID: 18551625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
    Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
    Front Immunol; 2020; 11():559342. PubMed ID: 33101276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.
    Bianchin MM; Capella HM; Chaves DL; Steindel M; Grisard EC; Ganev GG; da Silva Júnior JP; Neto Evaldo S; Poffo MA; Walz R; Carlotti Júnior CG; Sakamoto AC
    Cell Mol Neurobiol; 2004 Feb; 24(1):1-24. PubMed ID: 15049507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
    Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
    Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature.
    Montalbetti L; Soragna D; Ratti MT; Bini P; Buscone S; Moglia A
    Funct Neurol; 2004; 19(3):171-9. PubMed ID: 15595711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.